Study of Pharmacodynamic and Pharmacokinetic Interaction of Bojungikki-Tang with Aspirin in Healthy Subjects and Ischemic Stroke Patients

<div>The pharmacodynamic profiles of healthy subjects (phase I study). Data are shown as mean and standard deviation of thromboxane B2 (a) and platelet aggregation (b) in Bojungikki-tang (BJIKT) + aspirin and placebo + aspirin.</div>

Evidence-Based Complementary and Alternative Medicine

fig2

Figure 2

Figure 2: Study of Pharmacodynamic and Pharmacokinetic Interaction of Bojungikki-Tang with Aspirin in Healthy Subjects and Ischemic Stroke Patients 